首页 News文章正文

freespinsnodepositwinrealmoney|浙江医药上涨5.02% 券商给予买入建议

News 2024年05月06日 10:59 8 editor

If you want to speculate in the stock market, you can see the research report of Jin Kirin analysts.FreespinsnodepositwinrealmoneyAuthoritative, professional, timely, comprehensive, to help you tap the potential theme opportunities!

On May 06, the share price of Zhejiang Pharmaceutical (600216) rose sharply. As of 10:30, Zhejiang Pharmaceutical was up 5%.Freespinsnodepositwinrealmoney.02%, at 10.47 yuan per share, reaching a new high in nearly 3 months, breaking through the 10 yuan integer mark, with a turnover rate of 1.74% and a turnover rate of 173 million yuan.

In addition, data statistics show that in the past half a year, two brokerages give buying advice.

Capital trend

As of press time, Zhejiang Pharmaceutical received a net inflow of 25.37 million yuan, of which super-large single inflow was 17.76 million yuan and large single inflow was 7.61 million yuan. Data show that today's net inflow of the stock has increased by 18.84 million yuan compared with the average net inflow of nearly 5 days.

In terms of margin trading, Zhejiang Pharmaceutical received a net purchase of 5.47 million yuan on April 30, and the financing balance of the stock on that day was 470 million yuan, which increased by 1.18% over the previous day, achieving three consecutive increases; the margin balance of the stock was 5.09 million yuan, and the margin margin was 486600 shares, an increase of 20.21% over the previous day.

In terms of northbound funds, Zhejiang Pharmaceutical received a reduction of 561600 shares by northbound funds on April 30 for three consecutive days. As of April 30, northward funds currently hold a total of 16.0366 million shares in Zhejiang Pharmaceutical, with a market capitalization of 168 million yuan, accounting for 1.66% of the outstanding shares.

freespinsnodepositwinrealmoney|浙江医药上涨5.02% 券商给予买入建议

Main business and performance

Zhejiang Pharmaceutical Company is mainly engaged in life nutrition, pharmaceutical manufacturing products and pharmaceutical business.

According to the latest financial report, in the first quarter of this year, Zhejiang Pharmaceutical achieved 2.249 billion yuan in operating income, an increase of 12.01 percent over the same period last year, and its net profit was 110 million yuan, down 3.44 percent from the same period last year, and basic earnings per share was 0.11 yuan.

(the above content is Portfolio based on public information, intelligently generated by programs or algorithms, only as a reference for users to view the market, not as investment advice or transaction basis. The stock market is risky, please make a careful decision. )

相关文章

slots deposit bonus